NEW INVESTIGATIONAL CLINICAL STUDY USING A NEUFLO SYSTEM TO TREAT URINARY SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH)

Who can join?

  • Men aged 45 or older
  • Men not satisfied with their current treatment for BPH
  • Men who are able to attend regular check-ups with the study doctors

What to expect

This study involves an approx. 30 min procedure performed by a certified urologist. All participants enrolled in the study will receive a one-off treatment with the Neuflo System. The purpose of this study is to evaluate the safety and performance of the Neuflo System in relieving urinary symptoms secondary to Benign Prostatic Hyperplasia (BPH).

  • The study doctor will explain the possible risks and benefits involved with your participation.
  • There is no cost to participate in this study, undergo the procedure, or attend study-related visits.
  • Attend 5 to 6 post-procedure follow up visits over 12 months

DIAGNOSED WITH BENIGN PROSTATIC HYPERPLASIA?


ARE YOU AGED 45 OR OLDER?


CONTACT INFORMATION

UROLOGY CLINIC

Urology BOP
Suite 6, Level 1,
850 Cameron Road,
Tauranga 3112, NZ

PRINCIPAL INVESTIGATOR

Dr Peter Gilling

CONTACT DETAILS

Name: Margaret Ross
Email: marg@urobop.co.nz
Phone: (07) 577 7795

The Sponsor of this study is Prostacare Pty Ltd.
Neuflo Advertisement Version 1.0 07 Sep 2023